IP Library › Granted Patent US 7,354,901
Granted Patent B2
US 7,354,901 · App. 10/433,077 · Granted Apr 8, 2008

Production of recombinant BMP-2

Assignees: Rainer Rudolph; Elisabeth Schwarz
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,354,901
App. No.
10/433,077
Granted
Apr 8, 2008
Kind
B2
Abstract

In order to recombinantly prepare a biologically active protein of the TGF-β superfamily, a protein, whose amino terminus consists of the pro sequence of a protein of the TGF-β superfamily, or parts thereof, to which the mature domain of this protein or of another protein of TGF-β superfamily which exhibits at least 35% homology with mature BMP-2 is attached, is expressed in prokaryotes under conditions in which at least a part of the protein is obtained in the form of inclusion bodies, the inclusion bodies are isolated and solubilized under denaturing conditions, the denatured, monomeric and biologically inactive protein which has been solubilized from the inclusion bodies is renatured, with folding and dimerization to give the soluble, biologically active conformation and, where appropriate, after the renaturation, the mature protein is released proteolytically from its pro form.

Claims (4)

1. A method for promoting bone healing or producing bone replacement material or implants comprising administering to a subject in need thereof a therapeutically effective amount of recombinantly generated pro-BMP-2 wherein said pro-BMP-2 consists of an amino acid sequence which is (i) amino acids 22-284 of SEQ ID NO: 7, concatenated to (ii) amino acids 285-398 of SEQ ID NO: 7.

2. A composition for promoting bone growth comprising recombinantly generated pro-BMP-2, wherein said pro-BMP-2 consists of an amino acid sequence which is (i) amino acids 22-284 of SEQ ID NO: 7, concatenated to (ii) amino acids 285-398 of SEQ ID NO: 7, and a pharmaceutically acceptable carrier.

3. A method for promoting bone growth comprising administering to a subject in need thereof a therapeutically effective amount of recombinantly generated pro-BMP-2, wherein said pro-BMP-2 consists of an amino acid sequence which is (i) amino acids 22-284 of SEQ ID NO: 7, concatenated to (ii) amino acids 285-398 of SEQ ID NO:7.

4. The method of claim 3 , wherein said pro-BMP-2 is administered in the form of a preparation comprising a physiologically tolerated support material which is coated or impregnated with the pro-BMP-2.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2007
From: HERR, GERHARD
To: RUDOLPH, RAINER
Reel/Frame 019395/0937 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 6, 2006
From: HILLGER, FRANK
To: RUDOLPH, RAINER; SCHWARZ, ELISABETH; HERR, GERHARD
Reel/Frame 017740/0077 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2005
From: SCIL PROTEINS GMBH
To: RUDOLPH, RAINER; ELISABETH SCHWARZ; GERHARD HERR; FRANK HILLGER
Reel/Frame 016531/0872 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2003
From: RUDOLPH, RAINER; SCHWARZ, ELISABETH; HERR, GERHARD; HILLGER, FRANK
To: SCIL PROTEINS GMBH
Reel/Frame 014470/0927 →
Priority Claims (1)
DE 100 59 336 · Nov 29, 2000 · national
Continuity (1)
Related Publication 20040018595A1 · Jan 29, 2004